DSGN
Closed
Design Therapeutics Inc
3.52
+0.15 (+4.45%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 3.37
Day's Range: 3.33 - 3.6
Send
sign up or login to leave a comment!
When Written:
5.77
Design Therapeutics Inc is a biotechnology company that specializes in the development of small molecule therapies for serious genetic disorders. The company was founded in 2017 and is headquartered in San Diego, California. Its focus is on developing therapies for patients with nucleotide repeat expansion disorders, such as myotonic dystrophy type 1 (DM1) and Fragile X Syndrome (FXS).
Design Therapeutics Inc's approach is based on targeting RNA, which plays a critical role in the pathogenesis of nucleotide repeat expansion disorders. The company uses proprietary technology to identify and develop small molecules that target specific RNA structures, with the goal of correcting the underlying genetic defects that cause these disorders.
As of 2021, Design Therapeutics Inc is still in the preclinical stage of development, but it has raised significant funding from investors including SR One, Cormorant Asset Management, and Alexandria Venture Investments. The company has also entered into partnerships with leading academic institutions, including the University of Florida and the University of California, San Diego.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Design Therapeutics Inc's approach is based on targeting RNA, which plays a critical role in the pathogenesis of nucleotide repeat expansion disorders. The company uses proprietary technology to identify and develop small molecules that target specific RNA structures, with the goal of correcting the underlying genetic defects that cause these disorders.
As of 2021, Design Therapeutics Inc is still in the preclinical stage of development, but it has raised significant funding from investors including SR One, Cormorant Asset Management, and Alexandria Venture Investments. The company has also entered into partnerships with leading academic institutions, including the University of Florida and the University of California, San Diego.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!